Antifungal Prophylaxis: Impact on Outcomes of Newly Diagnosed AML Patients Treated with a Hypomethylating Agent and VenetoclaxEvan C. Chen, Jacqueline S. Garcia, Yiwen Liu et al.|Blood|2021Cited by 0
Post Allogeneic Stem Cell Transplant Outcomes Following Response to Hypomethylating Agent Therapy in Myelodysplastic Syndromes Are Predicted By Persistent International Prognostic Scoring System-Molecular RiskStacey M. Frumm, Maximilian Stahl, Haesook T. Kim et al.|Blood|2023Cited by 0
A Simple Prediction Model of Outcomes after Allogeneic Hematopoietic Stem Cell Transplant (HCT) in Myelodysplastic Syndromes Using HCT-Comorbidity Index, Cytogenetic Risk, and Platelet CountStacey M. Frumm, Maximilian Stahl, Haesook T. Kim et al.|Blood|2023Cited by 0
Measurable Residual Mutated NPM1 before Allogeneic Transplant for Acute Myeloid LeukemiaRasha W Al-Ali, Christopher S. Hourigan, Matt Holman et al.|Transplantation and Cellular Therapy|2025Cited by 0